Martin K. Casstevens

Martin K. Casstevens is the Business Formation and Commercialization Manager in the Office of Science, Technology Transfer and Economic Outreach (STOR) at the State University of New York (SUNY) at Buffalo (University at Buffalo, UB). In this position, he is responsible for or plays a role in startup business formation, entrepreneurial activities, technology valuations, incubator management, SBIR/STTR support/mentoring, venture financing, a business plan competition, and outreach functions. Mr. Casstevens is also the Director at the Directed Energy, a New York State Energy Research and Development Agency (NYSERDA) - funded virtual energy business incubator with clients in a wide range of technical areas. Mr. Casstevens has rich experiences in business management, administration and organization in his career. He was the General Manager and Senior Scientist at the Hybrid Technologies, LLC for 6 years and the Business Manager and Senior Scientist for more than four years at the Laser Photonics Technology, Inc. where he made great achievements both in his management role and in his scientific role. Under his leadership, LPT was profitable, developed many technological innovations in state-of-the-art laboratory facilities, and started several new business ventures including testing services, collaborations with strategic partners, and established two new companies - one committed to state-of-the-?art laser based medical analytical instruments and the other to holographic data recording. As a senior Scientist and PI, he led over two million dollars of externally funded research projects as well as being a staff scientist on all other projects in the company. He earned a BA in Psycho-Biology and did graduate work from 1982 to 1989 in the Biophysical Sciences Program under the guidance from both Dr. Robert Baier and Dr. Paras Prasad at UB. Therefore, beside his business management and administrative ability, Mr. Casstevens has strong scientific knowledge in surface chemistry and ultrafast laser spectroscopy of monomolecular films mimicking photosynthetic processes as well as in mass spectrometry, biochemistry, X-ray crystallography, polymer science, spectroscopy, and microscopy. He has more than 15 scientific publications and one issued patent. It is very fortunate for Canget BioTekpharma to have him as a member in the Business Advisory Board. Canget will benefit from his unique background in business, science, administration, and management experiences.